IP Verse

Celgene Corporation competitive analysis

Latest patents of Celgene Corporation opposed by its competitors

Explore Celgene Corporation's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3638243
Aug 7, 2024Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia2
EP3782612
Nov 8, 2023Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof5
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
EP2651400
Jan 18, 2023Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof1
EP3880802
Sep 7, 2022Improved T Cell Manufacturing Process1
EP3782611
Jul 6, 2022Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof5
EP3692983
Aug 11, 2021Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof7
EP3320902
Feb 17, 2021Methods For Treating Diseases Using Isoindoline Compounds1
EP2797581
May 6, 2020Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione3
EP2695609
Dec 11, 2019Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof4

Latest PTAB cases involving Celgene Corporation

Discover the latest PTAB cases involving Celgene Corporation, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 26, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Celgene Corporation

IPR2023-00512Feb 10, 2023APOTEXCELGENETerminated-Settled
IPR2018-01714Sep 12, 2018ALVOGEN PINE BROOKCELGENEInstitution Denied
IPR2018-01504Aug 3, 2018DR REDDYS LABORATORIESCELGENEInstitution Denied
IPR2018-01507Aug 3, 2018DR REDDYS LABORATORIESCELGENEInstitution Denied
IPR2018-01509Aug 3, 2018DR REDDYS LABORATORIESCELGENEInstitution Denied
IPR2018-00685Feb 23, 2018APOTEXCELGENEInstitution Denied
IPR2015-01169May 7, 2015COALITION FOR AFFORDABLE DRUGS VICELGENEInstitution Denied
IPR2015-01092Apr 23, 2015COALITION FOR AFFORDABLE DRUGS VICELGENEFinal Written Decision
IPR2015-01096Apr 23, 2015COALITION FOR AFFORDABLE DRUGS VICELGENEFinal Written Decision
IPR2015-01102Apr 23, 2015COALITION FOR AFFORDABLE DRUGS VICELGENEFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Celgene Corporation with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CELGENE - 72 - 11
GENERICS UK226 - - -
HOFFMANN EITLE149 - - -
TEVA PHARMACEUTICAL INDUSTRIES LTD2094 - -